Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Akeso Biopharma Inc (9926 HK)
Watchlist
211
Analysis
Health Care
•
China
Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Shanghai Junshi Biosciences
•
09 Jan 2023 08:55
Shanghai Junshi Bioscience (1877.HK/688180.CH)- Junshi Has Changed Its Story from Tumor to COVID-19?
After Junshi's story changed from tumor to COVID-19, we've lost sight of its future direction.The pipeline can't help Junshi turn loss into...
Xinyao (Criss) Wang
Follow
352 Views
Share
bullish
•
Thematic (Sector/Industry)
•
02 Jan 2023 08:55
China Healthcare Weekly (Jan.1) - NRDL Negotiation Turnaround, Pullback of TCM, Biotech Sales System
This year's NRDL negotiation could be “a landmark event” for innovative drug industry.Pullback of TCM may really begin from 23Q2.We analyzed...
Xinyao (Criss) Wang
Follow
448 Views
Share
bullish
•
Sichuan Kelun Pharmaceutical
•
27 Dec 2022 08:55
Merck Puts Eye-Popping $9.3B in ADC Deal with Kelun - The "New Story" Is About to Begin
After Merck gives up acquiring Seagen and fully embraces Kelun for the 3rd time, Kelun's outlook further brightened. Compared with Akeso/Summit...
Xinyao (Criss) Wang
Follow
858 Views
Share
bearish
•
Quantitative Analysis
•
27 Dec 2022 08:05
Hong Kong Connect Flows (Dec 23rd): Tencent, Kuaishou
We analyzed the Hong Kong Connect Scheme for last week and highlight flows for Tencent (700 HK), Kuaishou Technology (1024 HK).
Ke Yan, CFA, FRM
Follow
489 Views
Share
bullish
•
Quantitative Analysis
•
19 Dec 2022 08:00
Hong Kong Connect Flows (Dec 16th): Meituan, Tencent, China Mobile
We analyzed the Hong Kong Connect Scheme for last week and highlight inflows for Meituan, Tencent, and outflows from China Mobile.
Ke Yan, CFA, FRM
Follow
449 Views
Share
First
Previous
16
17
18
19
20
21
22
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x